MedPath
NMPA Approval

Peficitinib Hydrobromide Tablets

国药准字HJ20240076

July 30, 2024

Drug Information

氢溴酸吡西替尼片

施觅福

片剂

50mg(以C₁₈H₂₁N₄O₂计)

化学药品

July 30, 2024

July 29, 2029

Company Information

Applicant Company

5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8411, Japan

Manufacturing Company

astellas pharma inc. yaizu technology center

180 Ozumi, Yaizu-shi, Shizuoka 425-0072, Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氢溴酸吡西替尼片 - NMPA 批准文号 | MedPath